forecast

AI Mainly Helps Downstream Clinical Development

Alex is short-term pessimistic and long-term optimistic about AI for drug discovery, and he expects AI to help in the near term with downstream tasks such as regulatory documents, market analysis, and trial enrollment rather than with molecular design itself.

forecastpending

Speaker

Alex

Evidence Quote

“I'm much more optimistic about using AI in the short term to help drugs get to market faster”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...